- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
December 3, 2019 to December 4, 2019
General
The fourth annual Biomedical HIV Prevention Summit was held 3-4 December 2019 at the Marriott Marquis in Houston, Texas. NMAC believes we must highlight the role that biomedical prevention tools such as PrEP, PEP, Treatment as Prevention (TasP), and U=U have in ending the epidemic.
The conference’s logo represents a collaboration between community-based organizations (CBOs), health departments (HDs), and national organizations. Low uptake of PrEP among communities of color presents us with serious challenges regarding the populations that will not have the advantage of the protection offered by PrEP. This meeting brings together HIV leaders to discuss, learn, and share biomedical HIV prevention interventions.